Assessment of macrolide resistance in the respiratory tract of preterm-born infants during treatment with azithromycin in the AZTEC clinical trial
Macrolide-resistant genes were noticeably prevalent in the placebo group, with minimal increase with azithromycin treatment, suggesting that, regardless of the additional use of azithromycin, judicious use of antibiotics is required in preterm-born infants.
Authors
- Julian Roberto Marchesi (ORCID: https://orcid.org/0000-0002-7994-5239)
- Claudia Consoli
- Ali F. Aboklaish
- David J. Gallacher (ORCID: https://orcid.org/0000-0003-2548-3056)
- W. John Watkins
- Sailesh Kotecha
- John Lowe
Institutions
- University Hospital of Wales (GB)
- Imperial College London (GB)
- Cardiff University (GB)
Publication Details
- Journal
- Thorax
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1136/thorax-2025-224094
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00